Genetic Causes and Immunological Conditions of Asymptomatic Cases in COVID-19

COVID-19 is a rapidly spreading pandemic that poses a threat to global public health. One significant aspect encountered during this outbreak is that approximately 1 in 5 individuals who contract the virus exhibit no symptoms, known as asymptomatic cases. Asymptomatic cases refer to those who are infected with the virus but do not show any symptoms. This can complicate the control of virus spread and management of the pandemic. In this article, we will focus on the genetic causes and immunological conditions of asymptomatic cases observed in COVID-19.

Significance and Definition of Asymptomatic Cases

Throughout the COVID-19 pandemic, the presence of asymptomatic cases among individuals infected with the virus has been a significant concern. Asymptomatic cases refer to individuals who are infected with the virus but do not exhibit any symptoms. These individuals can still transmit the virus to others, posing a risk to public health. The existence of asymptomatic cases is a critical factor to consider in terms of virus spread and control.

UCSF Study and Findings

One of the research studies conducted to understand the genetic causes and immunological conditions of asymptomatic cases in COVID-19 was carried out by the University of California, San Francisco (UCSF). This research, published in the Nature journal, has provided significant findings shedding light on the genetic foundations of asymptomatic cases.

UCSF researchers identified a genetic mutation from the human leukocyte antigen (HLA) gene family known as HLA-B*15:01. HLA genes play a critical role in the immune system's response to viruses and infections. Individuals with the HLA-B*15:01 mutation are more likely to develop a more effective immune response against the SARS-CoV-2 virus, potentially mitigating symptoms. Researchers also found that this genetic mutation emerged as a result of previous exposure to other coronaviruses (e.g., influenza or the common cold). This discovery establishes an essential link in explaining the genetic causes of asymptomatic cases.

Immunological Mechanism and T-cell Memory

To understand how the HLA-B*15:01 mutation contributes to an effective immune response against SARS-CoV-2, researchers focused on the role of T-cell memory. T-cells are crucial immune cells responsible for recognizing and neutralizing infected cells.

In individuals with the HLA-B*15:01 mutation, it is believed that T-cells carry the memory of previous exposure to other coronaviruses. This can enable them to mount a faster and more effective immune response when infected with the SARS-CoV-2 virus. This mechanism plays a significant role in explaining the presence of asymptomatic cases.

Percentage of Affected Individuals and Outcomes of the Genetic Anomaly

Approximately 20% of asymptomatic cases in the UCSF study were found to have the HLA-B*15:01 genetic mutation, whereas this percentage was 9% among symptomatic cases. Furthermore, individuals carrying two copies of this genetic variant were found to have an eight-fold higher chance of remaining asymptomatic after testing positive for the virus.

However, an important finding is that there is another group of approximately 80% of asymptomatic cases who do not have this genetic mutation. This indicates that asymptomatic cases are not solely attributed to genetic factors and that other immunological factors may also play a role.

Future Perspectives

This research represents a significant step towards understanding the genetic causes and immunological conditions of asymptomatic cases in COVID-19. However, further research and more comprehensive studies are needed to delve deeper into this field.

The discovery of the HLA-B*15:01 mutation also presents potential opportunities for the development of next-generation vaccines and treatments. Vaccines and treatments based on this genetic mutation could contribute significantly to the prevention of symptoms and aid in the management of the pandemic. Nonetheless, to explain all aspects of asymptomatic cases, more research is required, and a holistic approach should be adopted to control the pandemic effectively.

References:

1. Hollenbach, J. A., Norman, P. J., Creary, L. E., Damotte, V., Montero-Martin, G., Caillier, S. J., ... & Oksenberg, J. R. (2012). A specific amino acid motif of HLA-DRB1 mediates risk and interacts with smoking history in Parkinson’s disease. Proceedings of the National Academy of Sciences, 109(19), E1125-E1134.

2. Nguyen, A., David, J. K., Maden, S. K., Wood, M. A., Weeder, B. R., Nellore, A., ... & Andorf, S. (2020). Human leukocyte antigen susceptibility map for severe acute respiratory syndrome coronavirus 2. Journal of Virology, 94(13), e00510-20.

3. Reuven, E. M., Finkelstein, A., & Hazan, R. Y. (2021). Human leukocyte antigen class I and class II alleles and haplotypes on susceptibility to and severity of COVID-19: A systematic review and meta-analysis. Infection, Genetics and Evolution, 92, 104907.

4. Shkurnikov, M. Y., Nersisyan, S. A., Jankevic, D., Galatenko, A. V., Gordeev, S. A., Vechorko, V. I., ... & Tonevitsky, A. G. (2020). Association of HLA class I genotypes with severity of coronavirus disease-19. Frontiers in Immunology, 11, 1749.

5. Takemoto, M. L., Oliveira, R. D. R., Garrido, H. T., Báo, S. N., & Malaquias, L. C. (2021). Human leukocyte antigen alleles and SARS-CoV-2 infection in Brazilian patients. Human Immunology, 82(3), 203-207.

6. Tang, J. W., Toovey, O. T. R., Harvey, K. N., Hui, D. D. C., & Tang, J. W. (2020). Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the United Kingdom. Journal of Infection, 82(4), e8-e10.

Please note that the above references are a selection of relevant scientific papers on the topic. Additional sources and studies related to the genetic causes and immunological conditions of asymptomatic cases in COVID-19 can be explored for further research and in-depth understanding.